Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Universidad Continental Inicio
Español
English
Buscar contenido en Universidad Continental
Inicio
Investigadores
Unidades de investigación
Producción científica
Premios
Actividades
Tesis
Severe Infections Due to Respiratory Viruses
Catia Cillóniz
, Juan M. Pericàs
, Jorge R. Rojas
, Antoni Torres
Producción científica
:
Artículo Científico
›
Artículo original
›
revisión exhaustiva
47
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Severe Infections Due to Respiratory Viruses'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Keyphrases
Respiratory Viruses
100%
Severe Infection
100%
Coronavirus
50%
Worse Outcome
50%
Community-acquired Pneumonia
50%
Influenza Virus
50%
Type 1 Diabetes Mellitus (T1DM)
25%
Streptococcus Pneumoniae
25%
Comorbidity
25%
Epidemiology
25%
Infection Risk
25%
Clinical Characteristics
25%
High Risk
25%
Asthma
25%
Co-infection
25%
Chronic Respiratory Diseases
25%
Clinical Practice
25%
Critically Ill Patients
25%
Viral Infection
25%
Severe Disease
25%
Influenza
25%
Severe Pneumonia
25%
Ventilator-associated Pneumonia
25%
Acute Respiratory Failure
25%
Clinical Prognosis
25%
Acute Respiratory Distress Syndrome
25%
Clinical Management
25%
Chronic Cardiovascular Diseases
25%
Staphylococcus Aureus
25%
Parainfluenza
25%
Metapneumovirus
25%
Rhinovirus
25%
Molecular Assay
25%
Severe Viral Pneumonia
25%
Adenovirus
25%
Respiratory Syncytial Virus
25%
Medicine and Dentistry
Infection
100%
Virus
100%
Influenza Virus
50%
Diabetes Mellitus
25%
Coronavirinae
25%
Mixed Infection
25%
Cardiovascular Disease
25%
Chronic Respiratory Tract Disease
25%
Cohort Effect
25%
Asthma
25%
Virus Infection
25%
Acute Respiratory Distress Syndrome
25%
Community-Acquired Pneumonia
25%
Staphylococcus Aureus
25%
Hospital-Acquired Pneumonia
25%
Ventilator-Associated Pneumonia
25%
Acute Respiratory Failure
25%
Pneumococcal Pneumonia
25%
Human Respiratory Syncytial Virus
25%
Viral Pneumonia
25%
Coronavirus
25%
Rhinovirus
25%
Parainfluenza
25%
Metapneumovirus
25%
Adenoviridae
25%
Comorbidity
25%
Streptococcus Pneumonia
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Respiratory Virus
100%
Influenza Virus
50%
Coronavirinae
25%
Diabetes Mellitus
25%
Mixed Infection
25%
Asthma
25%
Chronic Respiratory Tract Disease
25%
Virus Infection
25%
Staphylococcus Aureus
25%
Community Acquired Pneumonia
25%
Ventilator Associated Pneumonia
25%
Hospital Acquired Pneumonia
25%
Acute Respiratory Failure
25%
Adult Respiratory Distress Syndrome
25%
Human Respiratory Syncytial Virus
25%
Metapneumovirus
25%
Virus Pneumonia
25%
Rhinovirus
25%
Adenoviridae
25%
Cardiovascular Disease
25%
Streptococcus Pneumonia
25%
Comorbidity
25%
Diseases
25%
Immunology and Microbiology
Respiratory Virus
100%
Infection
100%
Influenza Virus
50%
Coinfection
25%
Viral Disease
25%
Influenza
25%
Asthma
25%
Adenoviridae
25%
Coronavirus
25%
Staphylococcus Aureus
25%
Metapneumovirus
25%
Coronavirinae
25%
Human Respiratory Syncytial Virus
25%
Rhinovirus
25%
Parainfluenza
25%
Comorbidity
25%
Streptococcus Pneumonia
25%
Cohort Effect
25%